The Need for Innovation in Pharma

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

0 comments

Post a comment

    Post a comment
    Embed Video
    Edit your comment Cancel

    6 Favorites

    The Need for Innovation in Pharma - Presentation Transcript

    1. Best Prac*ces for the Use of  Web 2.0 and Social Media Tools  for Internal Collabora*on  Erik van der Zijden BSc MBA Innova,on Manager
    2. Erik van der Zijden Yara The Netherlands Floortje 1972 BSc Akzo Nobel Pharma 1995 MBA Area Management Intervet 1998 Export Sales Balkans Interna,onal Marke,ng Global Product Manager Equine     An,parasi,cs Innova,on Manager Intervet/Schering‐Plough  Enterprise 2.0 Mar,al Arts Podcas,ng Social Media Triumph SpiNire
    3. 1 Innova*on | why needed? 2 Social Media & Collabora*on | background 3 How we did it | Best prac,ces 4 Tips & Tricks
    4. Conclusion
    5. 1 Innova*on | why?
    6. Innova*on | why? 1 Less products in pipeline Less diversifica,on in products Patent expiry Generic pressure Global branding versus local adapta,on Low on trust Pa,ents more informed Pricing pressure More regulatory involvement
    7. Innova*on | why? 1 “ It’s a plug and play world. Because you can  now innovate without having to emigrate,  more and more world‐class innova,on is  “ now star,ng from India Thomas L. Friedman ‐ The World is Flat
    8. Innova*on | why? 1 The growth of intangibles Market value in  trillions USD Human capital 7,5 Know‐how Trademarks Goodwill Collabora,on ac,vi,es .... 4,7 0,8 1,4 Intangible Capital 1985 Financial Capital 2005 Analysis of the biggest 150 companies in the world from 1985 All 2005
    9. Innova*on | why? 1 “ Pharma will not only make white powders;  it will sell a variety of products and  therapeu,c healthcare packages, as well as  a wide range of services to support pa,ents  “ Pharma 2010: The Threshold of InnovaAon ‐ IBM Future Series
    10. Innova*on | why? 1 Staatscourant 18th August 2008 Dutch Ministry of Health R&D‐spending in 3 industry sectors (€ 8 bln turnover) Biotechnology PharmaceuAcal industry Medical technology
    11. Innova*on | why? 1 Staatscourant 18th August 2008 Main outcomes RelaAve high R&D‐investments (€ 1 bln or 12,5% of sales) Return on each € invested in R&D: € 1,1 (industry avg. € 3,0) InnovaAon is not managed correctly
    12. Innova*on | why? 1 Staatscourant 18th August 2008 Recommenda*ons Reduce top‐down approach in InnovaAon Management Boost creaAvity and enthusiasm within the workforce Strengthen 3rd‐party collaboraAon, also across the border
    13. n Innova*on | why? 1 ov te
    14. Innova*on | why? 1 So, what is innova*on anyway?
    15. Innova*on | why? 1 ‐e in•no•vate   | in   vat| ‐ “ ‐ A new way of doing something. It may refer  to incremental, radical, and revolu,onary  changes in thinking, products, processes, or  “ organiza,ons.  *on crea lue  Va wikipedia.org
    16. h Innova*on | why? 1 n e
    17. Innova*on | why? 1 “ People are very open‐minded about new things  ‐ as long as they’re exactly like the old ones. “ Charles KeWering
    18. Innova*on | why? 1 Locked innova*on process Too busy with today’s things Market research, but no customer insights Customers involved too late or never Trapped by old company successes Risk averse Try new ini,a,ves only once Urgency only when pain (compe,,on, decreasing  turnover) Internal research
    19. 1 Innova*on | why needed? 2 Social Media & Collabora*on | background
    SlideShare Zeitgeist 2009

    + DigiRedo DigiRedo Nominate

    custom

    710 views, 6 favs, 0 embeds more stats

    In this episode you can see the first part of Erik' more

    More info about this document

    © All Rights Reserved

    Go to text version

    • Total Views 710
      • 710 on SlideShare
      • 0 from embeds
    • Comments 0
    • Favorites 6
    • Downloads 0
    Most viewed embeds

    more

    All embeds

    less

    Flagged as inappropriate Flag as inappropriate
    Flag as inappropriate

    Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

    Cancel
    File a copyright complaint
    Having problems? Go to our helpdesk?

    Categories